Usefulness of ezetimibe versus evolocumab as add-on therapy for secondary prevention of cardiovascular events in patients with type 2 diabetes mellitus
Arbel R, Hammerman A, Azuri J
The American Journal of Cardiology. Pub. online 23 January 2019
Leggi